Heyholder
‹ Back to the disclosure you were reading

Dong-A Pharmaceutical Co.,Ltd. New non-registered executive reports holding of 220 common shares

Dong-A Pharmaceutical Co.,Ltd.· Insider Ownership

AI summary · Not investment advice

Newly appointed non-registered executive Lee Sang-won reported holding 220 common shares (0.00%) as of November 6, 2026.

Key facts

Reporting person
Lee Sang-won
Relationship with issuer
Non-registered executive, Senior Managing Director candidate (Sangmu-bo)

Commentary

AI commentary · Not investment advice

What happened

A newly appointed executive at Dong-A Pharmaceutical, Lee Sang-won, reported owning 220 common shares of the company.

In the company's terms

He is an unregistered executive (an officer not on the board) with the title of Sangmubo. He was newly appointed, so he had to report his holdings. His ownership ratio is 0.00%.

Earlier Insider Ownership filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.11.06Insider Ownership67 shares · Common shares held following new appointment
26.11.06Insider Ownership30 shares
26.11.06Insider Ownership26 shares · New report, common shares

Comments

No comments yet

Comments from shareholders will appear here.